Doctors are going to tell you to take down your stress level, which, in theory, is a great idea. But there’s always going to be the next deadline, the next stolen credit card number, the next headline ...
Alterity Therapeutics (ASX:ATH) CEO Dr David Stamler presented new analyses from the phase II double-blinded ATH434-201 trial in MSA, showing positive effects on slowing disease progression and ...
A new study reveals that young women with symptomatic long COVID may be at higher risk of developing a chronic condition ...
A copy of the Company’s presentation will be available under the Presentations tab of the Tonix website at https://ir.tonixpharma.com/presentations following the conference. Additional meeting ...
Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...